Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q1 FY21 results · Apr–Jun 2020

Insecticides (India) reported revenue from operations of ₹409.60 crore (up 14.3% from Q1 FY20) and net profit of ₹24.36 crore (down 32.5% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.

Consolidated · ₹ crore
Item	Q1 FY21	Q1 FY20	YoY	Q4 FY20	QoQ
Revenue from operations	409.60	358.36	+14.3%	238.67	+71.6%
Other income	1.12	1.17	−4.0%	(0.92)	Turned profit
Total income	410.72	359.53	+14.2%	237.75	+72.8%
Profit before share of associates & JVs and tax	31.99	51.52	−37.9%	(14.66)	Turned profit
Share of profit/(loss) of associates & JVs	0.28	0.17		0.20
Net profit for the period	24.36	36.11	−32.5%	(7.11)	Turned profit
EPS, basic (₹)	11.79	17.47	−32.5%	(3.54)	Turned profit
Net margin (%)	5.9	10.1		-3.0

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q1 FY21	Q1 FY20	YoY	Q4 FY20	QoQ
Revenue from operations	409.60	358.36	+14.3%	238.67	+71.6%
Other income	1.12	1.17	−4.0%	(0.92)	Turned profit
Total income	410.72	359.53	+14.2%	237.75	+72.8%
Profit before tax	31.99	51.52	−37.9%	(14.66)	Turned profit
Net profit for the period	24.08	35.94	−33.0%	(7.32)	Turned profit
EPS, basic (₹)	11.65	17.39	−33.0%	(3.54)	Turned profit
Net margin (%)	5.9	10.0		-3.1

Consolidated

Filed with BSE: 14 Aug 2020, 18:04 IST
Board meeting: 14 Aug 2020
Period: 01 Apr 2020 to 30 Jun 2020
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 14 Aug 2020, 18:04 IST
Board meeting: 14 Aug 2020
Period: 01 Apr 2020 to 30 Jun 2020
Review status: Unaudited
Source: XBRL filing on BSE